Encapsulating cells in biodegradable hydrogels offers numerous attractive features for tissue engineering, including ease of handling, a highly hydrated tissue-like environment for cell and tissue growth, and the ability to form in vivo. Many properties important to the design of a hydrogel scaffold, such as swelling, mechanical properties, degradation, and diffusion, are closely linked to the crosslinked structure of the hydrogel, which is controlled through a variety of different processing conditions. Degradation may be tuned by incorporating hydrolytically or enzymatically labile segments into the hydrogel or by using natural biopolymers that are susceptible to enzymatic degradation. Because cells are present during the gelation process, the number of suitable chemistries and formulations are limited. In this review, we describe important considerations for designing biodegradable hydrogels for cell encapsulation and highlight recent advances in material design and their applications in tissue engineering.
Six vinyl-based, imidazolium room-temperature ionic liquid
(RTIL)
monomers were synthesized and photopolymerized to form dense poly(RTIL)
membranes. The effect of polymer backbone (i.e., poly(ethylene), poly(styrene),
and poly(acrylate)) and functional cationic substituent (e.g., alkyl,
fluoroalkyl, oligo(ethylene glycol), and disiloxane) on ideal CO2/N2 and CO2/CH4 membrane
separation performance was investigated. The vinyl-based poly(RTIL)s
were found to be generally less CO2-selective compared
to analogous styrene- and acrylate-based poly(RTIL)s. The CO2 permeability of n-hexyl- (69 barrers) and disiloxane-
(130 barrers) substituted vinyl-based poly(RTIL)s were found to be
exceptionally larger than that of previously studied styrene and acrylate
poly(RTIL)s. The CO2 selectivity of oligo(ethylene glycol)-functionalized
vinyl poly(RTIL)s was enhanced, and the CO2 permeability
was reduced when compared to the n-hexyl-substituted
vinyl-based poly(RTIL). Nominal improvement in CO2/CH4 selectivity was observed upon fluorination of the n-hexyl vinyl-based poly(RTIL), with no observed change
in CO2 permeability. However, rather dramatic improvements
in both CO2 permeability and selectivity
were observed upon blending 20 mol % RTIL (emim Tf2N) into
the n-hexyl- and disiloxane-functionalized vinyl
poly(RTIL)s to form solid–liquid composite films.
While designing poly(ethylene glycol) hydrogels with high moduli suitable for in situ placement is attractive for cartilage regeneration, the impact of a tighter crosslinked structure on the organization and deposition of matrix is not fully understood. The objectives for this study were to characterize the composition and spatial organization of neo-matrix as a function of gel crosslinking and study its impact on chondrocytes via anabolic and catabolic gene expressions and catabolic activity. Bovine articular chondrocytes were encapsulated in hydrogels of three crosslinking densities (compressive moduli were 60, 320 and 590 kPa) and cultured for 25 days. Glycosaminoglycan production increased with culture time and was greatest in gels with lowest crosslinking. Collagens II and VI, aggrecan, link protein, and decorin were localized to pericellular regions in all gels, but their presence decreased with increases in gel crosslinking. Collagen II and aggrecan expressions were initially up-regulated in gels with higher crosslinking, but increased similarly up to day 15. Matrix metalloproteinases (MMP)-1 and -13 expressions were elevated (~25-fold) in gels with higher crosslinking throughout the study, while MMP-3 was not affected by gel crosslinking. The presence of aggecan and collagen degradation products confirmed MMP activity. These findings indicate that chondrocytes synthesize the major cartilage components within PEG hydrogels, however, gel structure strongly impacts the composition and spatial organization of the neo-tissue and impacts how chondrocytes respond to their environment, particularly with respect to their catabolic expressions.
Crosslinked poly(ethylene glycol) (PEG) hydrogels are attractive scaffolds for cartilage tissue engineering because of their ability to mimic the aqueous environment and mechanical properties of native cartilage. In this study, hydrogel crosslinking density was varied to study the influence of gel structure and the application of dynamic loading (continuous, 1 Hz, 15% amplitude strain) on chondrocyte gene expression over ∼1 week culture. Gene expression was quantified using real time RT-PCR for collagen II and aggrecan, the major cartilage extracellular matrix (ECM) components, and collagen I, an indicator of chondrocyte de-differentiation. When chondrocytes were encapsulated in PEG gels with low or high crosslinking, a high collagen II expression compared to collagen I expression (1,000 or 100,000:1, respectively) indicated the native chondrocyte phenotype was retained. In the absence of loading, relative gene expression for collagen II and aggrecan was significantly higher (e.g., 2-fold and 4-fold, respectively, day 7) in the low crosslinked gels compared to gels with higher crosslinking. Dynamic loading, however, showed little effect on ECM gene expression in both crosslinked systems. To better understand the cellular environment, ECM production was qualitatively assessed using an in situ immunofluorescent technique and standard histology. A pericellular matrix (PCM) was observed as early as day 3 post-encapsulation and the degree of formation was dependent on gel crosslinking. These results suggest the PCM may protect the cells from sensing the applied loads. This study demonstrates that gel structure has a profound effect on chondrocyte gene expression, while dynamic loading has much less of an effect at early culture times.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.